Edwards Lifesciences Corporation Share-based Payment Arrangement, Expense, after Tax
Edwards Lifesciences Corporation (EW) reported Share-based Payment Arrangement, Expense, after Tax of $35.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-08-04
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for the quarter ending 2026-06-30 was $35.20M, a 12.10% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for the quarter ending 2026-03-31 was $37.90M, a 12.80% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for the quarter ending 2025-12-31 was $31.60M, a 17.91% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for the quarter ending 2025-09-30 was $33.30M, a 14.04% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for fiscal 2025 was $129.90M, a 7.53% increase from fiscal 2024.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for fiscal 2024 was $120.80M, a 17.28% increase from fiscal 2023.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for fiscal 2023 was $103.00M, a 9.57% increase from fiscal 2022.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, after tax for fiscal 2022 was $94.00M, a 3.98% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 3 month as first filed | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 6 month as first filed | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 9 month as first filed | Share-based Payment Arrangement, Expense, after Tax 12 month | Share-based Payment Arrangement, Expense, after Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.20M 10-Q · filed 2026-08-04 | $73.10M 10-Q · filed 2026-08-04 | $104.70M derived: sum of 3 quarters · filed 2026-08-04 | $138.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $37.90M 10-Q · filed 2026-05-06 | $69.50M derived: sum of 2 quarters · filed 2026-05-06 | $102.80M derived: sum of 3 quarters · filed 2026-05-06 | $134.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $31.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $64.90M derived: sum of 2 quarters · filed 2026-02-25 | $96.30M derived: sum of 3 quarters · filed 2026-08-04 | $129.90M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $33.30M 10-Q · filed 2025-11-05 | $64.70M derived: sum of 2 quarters · filed 2026-08-04 | $98.30M 10-Q · filed 2025-11-05 | $125.10M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $31.40M 10-Q · filed 2026-08-04 | $65.00M 10-Q · filed 2026-08-04 | $91.80M derived: sum of 3 quarters · filed 2026-08-04 | $121.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $33.60M 10-Q · filed 2026-05-06 | $60.40M derived: sum of 2 quarters · filed 2026-05-06 | $89.60M derived: sum of 3 quarters · filed 2026-05-06 | $120.90M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $26.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $56.00M derived: sum of 2 quarters · filed 2026-02-25 | $87.30M derived: sum of 3 quarters · filed 2026-02-25 | $120.80M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $29.20M 10-Q · filed 2025-11-05 | $60.50M derived: sum of 2 quarters · filed 2025-11-05 | $94.00M 10-Q · filed 2025-11-05 | $114.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $31.30M 10-Q · filed 2025-08-06 | $31.50M 10-Q · filed 2024-07-31 | $64.80M 10-Q · filed 2025-08-06 | $65.00M 10-Q · filed 2024-07-31 | $85.00M derived: sum of 3 quarters · filed 2026-02-25 | $109.40M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $33.50M 10-Q · filed 2025-05-06 | $38.40M 10-Q · filed 2024-04-29 | $53.70M derived: sum of 2 quarters · filed 2026-02-25 | $78.10M derived: sum of 3 quarters · filed 2026-02-25 | $106.30M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $44.60M derived: sum of 2 quarters · filed 2026-02-25 | $72.80M derived: sum of 3 quarters · filed 2026-02-25 | $103.00M 10-K · filed 2026-02-25 | $115.30M 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $24.40M 10-Q · filed 2024-11-06 | $26.80M 10-Q · filed 2023-10-27 | $52.60M derived: sum of 2 quarters · filed 2024-11-06 | $82.80M 10-Q · filed 2024-11-06 | $91.60M 10-Q · filed 2023-10-27 | $97.10M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $28.20M 10-Q · filed 2024-07-31 | $30.60M 10-Q · filed 2023-07-28 | $58.70M 10-Q · filed 2024-07-31 | $64.80M 10-Q · filed 2023-07-28 | $72.70M derived: sum of 3 quarters · filed 2025-02-28 | $98.10M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $34.20M 10-Q · filed 2024-04-29 | $44.50M derived: sum of 2 quarters · filed 2025-02-28 | $69.90M derived: sum of 3 quarters · filed 2025-02-28 | $100.20M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $35.70M derived: sum of 2 quarters · filed 2025-02-28 | $66.00M derived: sum of 3 quarters · filed 2025-02-28 | $94.00M 10-K · filed 2025-02-28 | $105.20M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $25.40M 10-Q · filed 2023-10-27 | $55.70M derived: sum of 2 quarters · filed 2023-10-27 | $83.70M 10-Q · filed 2023-10-27 | $102.50M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $30.30M 10-Q · filed 2023-07-28 | $58.30M 10-Q · filed 2023-07-28 | $77.10M derived: sum of 3 quarters · filed 2024-02-12 | $99.00M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $28.00M 10-Q · filed 2023-04-28 | $46.80M derived: sum of 2 quarters · filed 2024-02-12 | $68.70M derived: sum of 3 quarters · filed 2024-02-12 | $94.10M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $18.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $40.70M derived: sum of 2 quarters · filed 2024-02-12 | $66.10M derived: sum of 3 quarters · filed 2024-02-12 | $90.40M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $21.90M 10-Q · filed 2022-10-28 | $47.30M derived: sum of 2 quarters · filed 2022-10-28 | $71.60M 10-Q · filed 2022-10-28 | $88.60M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $25.40M 10-Q · filed 2022-07-29 | $49.70M 10-Q · filed 2022-07-29 | $66.70M derived: sum of 3 quarters · filed 2023-02-13 | $85.80M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $24.30M 10-Q · filed 2022-04-28 | $41.30M derived: sum of 2 quarters · filed 2023-02-13 | $60.40M derived: sum of 3 quarters · filed 2023-02-13 | $81.10M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $36.10M derived: sum of 2 quarters · filed 2023-02-13 | $56.80M derived: sum of 3 quarters · filed 2023-02-13 | $77.20M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $19.10M 10-Q · filed 2021-10-29 | $39.80M derived: sum of 2 quarters · filed 2021-10-29 | $60.20M 10-Q · filed 2021-10-29 | |||||
| 2020-06-30 | $20.70M 10-Q · filed 2021-07-30 | $41.10M 10-Q · filed 2021-07-30 | ||||||
| 2020-03-31 | $20.40M 10-Q · filed 2021-04-28 | |||||||
| 2019-12-31 | $66.50M 10-K · filed 2022-02-14 | |||||||
| 2018-12-31 | $57.60M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |